Ultrasound-guided prostate brachytherapy system receives FDA clearance

11/22/2013 | AuntMinnie.com (free registration)

CIVCO Medical Solutions has been cleared by the FDA to market its EX3 Stepper system for use in the diagnosis and treatment of prostate cancer. The company said the ultrasound-guided device, designed for both high-dose-rate and low-dose-rate brachytherapy, also received CE mark approval.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI